Epidemiology Study of Non-arteritic Anterior Ischemic Optic Neuropathy (NAION)

The study population consisted of members of the Ingenix Normative Health Informatics (NHI) Database during 01/01/2003 through 12/31/2007, who were 18 years of age or older with at least 183 days of continuous enrollment in the database and without any doctor visits associated with a diagnosis of ischemic optic neuropathy during the 183 days prior to cohort entry.

From the study population, patients with a claim associated with an ischemic optic neuropathy diagnosis code were identified as potential NAION cases (n = 3,732). From the potential NAION cases, definite and possible NAION cases were identified using medical record review and a claims algorithm (n=1,283).

From the study population, patients without a claim associated with an ischemic optic neuropathy diagnosis code were randomly selected as controls (n = 20,000)

• Anterior Ischemic Optic Neuropathy
• Ischemic Optic Neuropathy

• NAION cases
  
  From the study population, patients with a claim associated with an ischemic optic neuropathy diagnosis code were identified as potential NAION cases (n = 3,732). From the potential NAION cases, definite and possible NAION cases were identified using medical record review and a claims algorithm (n=1,283). Data from definite and possible NAION cases contributed to the analysis.
  Intervention: Other: No intervention given in this observational study
• Controls
  
  From the study population, patients without a claim associated with an ischemic optic neuropathy diagnosis code were randomly selected as controls (n = 20,000)
  Intervention: Other: No intervention given in this observational study

Inclusion Criteria:

• Member of the Ingenix Normative Health Informatics (NHI) Database during 01/01/2003 through 12/31/2007
• 18 years of age or older
• Had at least 183 days of continuous enrollment in the database
• No doctor visits associated with a diagnosis of ischemic optic neuropathy during the 183 days prior to cohort entry

Exclusion Criteria:

• Less than 18 years of age
• Less than 183 days of continuous enrollment in the database
• At least one doctor visit associated with a diagnosis of ischemic optic neuropathy during the 183 days prior to cohort entry